Newell Joe 4
4 · Atara Biotherapeutics, Inc. · Filed Sep 24, 2021
Insider Transaction Report
Form 4
Newell Joe
Chief Tech. Operations Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-22$12.15/sh+10,500$127,575→ 130,429 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-09-22$17.00/sh−8,375$142,375→ 34,875 totalExercise: $12.15Exp: 2030-02-28→ Common Stock (8,375 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-09-22$17.00/sh−2,125$36,125→ 10,625 totalExercise: $12.15Exp: 2030-02-28→ Common Stock (2,125 underlying) - Sale
Common Stock
2021-09-22$17.00/sh−10,500$178,500→ 119,929 total
Footnotes (2)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.
- [F2]1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.